Cargando…

Handbook of Graphene Materials.

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Tiwari, Ashutosh
Otros Autores: Harun, Sulaiman Wadi
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Newark : John Wiley & Sons, Incorporated, 2019.
Temas:
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Cover
  • Title Page
  • Copyright Page
  • Contents
  • Preface
  • 1 Biological, Biomedical, and Medical Applications of Graphene and Graphene-Based Materials (G-bMs)
  • 1.1 Introduction
  • 1.2 Advent of Graphene
  • 1.3 Importance of Graphene
  • 1.4 Biological Applications of Graphene and G-bMs
  • 1.4.1 Biosensing and Bioimaging
  • 1.4.2 Biotargeting
  • 1.4.3 Biomarking and Biorecognition
  • 1.5 Medical and Biomedical Applications of Graphene and G-bMs
  • 1.5.1 Drug Delivery Applications of Graphene and G-bMs
  • 1.5.2 Antibacterial Applications of Graphene and G-bMs
  • 1.6 Challenges and Future Trend
  • 1.7 Conclusion
  • References
  • 2 Effect of Graphene Oxide Nanosheets on the Structure and Properties of Cement Composites
  • 2.1 Introduction
  • 2.2 Preparation and Structural Characteristics of GO Nanosheets
  • 2.2.1 Preparation of GO Nanosheets
  • 2.2.2 Structural Characteristics of GO Nanosheets
  • 2.3 Preparation of Cement Composites with GO Nanosheets
  • 2.4 Effect of GO Nanosheets on the Microstructure and Performances of Cement Composites
  • 2.4.1 Effects of GO Nanosheet Dosages on the Microstructure and Performances of Cement Composites
  • 2.4.2 Effect of GO Nanosheets with Different Oxygen Contents on the Microstructure and Performances of Cement Composites
  • 2.4.3 Effect of Hydration Times on the Microstructure and Mechanical Properties of Cement Composites
  • 2.4.4 Effect of GO Nanosheet Size on the Microstructure and Mechanical Properties of Cement Composites
  • 2.4.5 Effect of GO Nanosheets on the Pore Structure of Hardened Cement Paste
  • 2.5 Preparation of Cement Composites with Large-Scale Ordered Microstructures by Doping Few-Sheet GO Nanosheets and Investigation of Their Structure and Performance
  • 2.5.1 Preparation of Few-Sheet GO Nanosheets by Forming CCS/GO Intercalation Composites.
  • 2.5.2 Preparation of Large-Scale and Large-Volume Ordered Structural Cement Composites
  • 2.5.3 Mechanical Properties and Durability Parameters of Cement Composites
  • 2.6 Effect of GO Nanosheets on the Crystal Structure of Cement Hydration Crystals
  • 2.7 Formation Mechanism of Regular-Shaped Cement Hydration Crystals and Ordered Microstructure
  • 2.7.1 Regulation Mechanism of GO Nanosheets on Cement Hydration Products
  • 2.7.2 Forming Mechanism of Large-Scale Regular Hydration Crystals and Large-Volume Ordered Microstructure of Cement Composites
  • 2.7.3 Experiment Base of the Forming Mechanism of Regular Cement Composites
  • 2.8 Conclusion and Future Trends
  • References
  • 3 Adaptation and Viability of Graphene-Based Materials in Clinical Improvement
  • 3.1 Introduction
  • 3.2 Biomedical Properties of Graphene
  • 3.3 Optical and Biological Properties of Graphene
  • 3.4 Safety and Sustainability of Graphene in Medical Application
  • 3.5 Laboratory Preparation of Graphene
  • 3.6 Graphene-Based Materials and Its Risk Index
  • 3.7 Applications of Graphene-Based Materials in Clinical Improvement
  • 3.7.1 Tissue Engineering
  • 3.7.2 Modified Graphene Material in Gene Delivery
  • 3.7.3 Drug Delivery
  • 3.8 Combination of Graphene in Polymer-Based Composites for Improved Bioactivities
  • 3.9 Application of Graphene in Metal-Matrix Formation for Biomedical Applications
  • 3.10 Conclusion and Future Outlook
  • Acknowledgments
  • References
  • 4 Graphene-Based Synaptic Devices for Neuromorphic Applications
  • 4.1 Basics of Neuromorphic Computing
  • 4.1.1 Demand for Devices for Neuromorphic Applications
  • 4.1.2 Basics of Biological Synapse
  • 4.1.3 Basic Work Principle of Synaptic Devices
  • 4.1.3.1 RRAM Used as Synaptic Device
  • 4.1.3.2 Transistor Used as Synaptic Device
  • 4.2 Introduction of Graphene.
  • 4.3 Graphene Used as the Inserted Layer in RRAM Devices
  • 4.3.1 Reasons for Choosing Graphene as the Inserted Layer in RRAM
  • 4.3.2 Device Structure Comparison
  • 4.3.3 Device Fabrication
  • 4.3.4 Use of Graphene
  • 4.3.4.1 Monitoring Oxygen Movement by Raman Spectrum
  • 4.4 Graphene Used as the Electrode in RRAM Devices
  • 4.4.1 Reasons for Choosing Graphene as an Electrode in RRAM
  • 4.4.1.1 Flexible Electrode
  • 4.4.1.2 Feasibility for Large-Scale Production
  • 4.4.1.3 Gate Tunability
  • 4.4.1.4 Ability to Catch Oxygen Ions
  • 4.4.2 Graphene-Based Fin Structure RRAM
  • 4.4.2.1 Advantages of Fin Structure
  • 4.4.2.2 LSG-The Approach to Form Fin-Like Structure
  • 4.4.2.3 Device Fabrication Process
  • 4.4.2.4 Electrical Properties
  • 4.4.2.5 Mechanism of the Device
  • 4.4.2.6 Future Prospect
  • 4.4.3 Gate-Controlled BLG-Electrode RRAM
  • 4.4.3.1 Reasons for Using Gate-Controlled RRAM
  • 4.4.3.2 Device Fabrication Process
  • 4.4.3.3 Electrical Properties
  • 4.4.3.4 Mechanism of This Device
  • 4.4.3.5 Future Prospect
  • 4.5 From RRAM to Synaptic Device
  • 4.5.1 Dual Mode in BLG-Based Artificial Synaptic Device
  • 4.5.1.1 Inhibitory Synaptic Device: The Way to Mimic the "Learning" Process
  • 4.5.1.2 Device Fabrication
  • 4.5.1.3 Electrical Properties and Mechanism
  • 4.5.1.4 Further Prospect
  • 4.5.2 Graphene Dynamic Synapse with Modulatable Plasticity
  • 4.5.2.1 Modulatable Plasticity
  • 4.5.2.2 Device Structure and Fabrication
  • 4.5.2.3 Hysteresis and Its Origin
  • 4.5.2.4 Reason for Using Twisted BLG
  • 4.5.2.5 Electrical Properties
  • 4.5.2.6 Future Prospect
  • 4.6 Prospect
  • 4.7 Conclusion
  • References
  • 5 Graphene-Based Materials for Implants
  • 5.1 Introduction
  • 5.2 Graphene-Based Materials
  • 5.2.1 Synthesis and Properties
  • 5.2.1.1 Graphene Oxide (GO)
  • 5.2.1.2 Reduced GO (rGO)
  • 5.2.1.3 Graphene Nanomaterials.
  • 5.2.2 Applications of GBMs
  • 5.2.3 Implants
  • 5.2.3.1 Orthopedic Implants
  • 5.2.3.2 Dental Implants
  • 5.2.3.3 Drug Delivery Implants
  • 5.2.3.4 Biosensor Implants
  • 5.2.4 Biodegradation and Elimination
  • 5.2.5 Toxicity
  • 5.3 Conclusion
  • Acknowledgments
  • References
  • 6 Ultrashort Pulse Fiber Laser Generation Using Molybdenum Disulfide and Tungsten Disulfide Saturable Absorber
  • 6.1 Introduction
  • 6.2 Background of Fiber Laser
  • 6.3 Mode-Locked Fiber Laser
  • 6.3.1 Saturable Absorber
  • 6.4 Transition Metal Dichalcogenides
  • 6.4.1 Tungsten Disulfide
  • 6.4.2 Molybdenum Disulfide
  • 6.5 Fabrication and Characterization of SA
  • 6.6 Fiber Laser Configuration
  • 6.7 Performance of Ultrashort Laser with WS2 SA
  • 6.8 Performance of Ultrashort Laser with MoS2 SA
  • 6.9 Summary
  • References
  • 7 Graphene-Modified Asphalt
  • 7.1 Introduction
  • 7.2 Molecular Simulations and Experiments
  • 7.2.1 GMA and the Interfacial Model of Graphene and Asphalt
  • 7.2.2 Thermomechanical Properties of GMA
  • 7.2.2.1 Thermal Expansion Coefficient Calculation
  • 7.2.2.2 Thermal Conductivity Calculation
  • 7.2.2.3 Shear Modulus Calculation
  • 7.2.2.4 Elastic Constants and Modulus Calculation
  • 7.2.2.5 Glass Transition Temperature and Thermal Properties
  • 7.2.3 Interfacial Behavior of Graphene and Asphalt
  • 7.2.3.1 Interface Mechanical Behavior
  • 7.2.3.2 Interface Energy Calculation
  • 7.2.3.3 Interface Interaction
  • 7.2.3.4 Interface Failure Modes
  • 7.2.4 Self-Healing Properties of GMA and Mortar
  • 7.2.4.1 Reaction Energy Barrier of Self-Healing
  • 7.2.4.2 Healing Index
  • 7.2.4.3 Self-Healing Properties
  • 7.2.4.4 Self-Healing Time
  • 7.3 Conclusion
  • Acknowledgments
  • References
  • 8 Graphene-Based Materials for Brain Targeting
  • 8.1 Introduction
  • 8.2 Graphene-Based Biomaterials
  • 8.3 Drug Delivery to the Brain.
  • 8.3.1 Route of Transportation of Drug Across the BBB
  • 8.3.1.1 Paracellular Transport Route in Brain-Diseased State
  • 8.3.1.2 Transcellular Transport Route in Brain-Diseased State
  • 8.3.1.3 Mode of Transport Across the Brain
  • 8.4 Graphene-Based Drug Delivery Systems
  • 8.4.1 Graphene-Based Drug Delivery Systems for the Treatment of Brain Cancer
  • 8.4.2 Graphene-Based Systems for Diagnostic Application and Drug Delivery for the Treatment of AD
  • 8.4.3 Graphene-Based Drug Delivery Systems for the Treatment of Subarachnoid Hemorrhage
  • 8.4.4 Graphene-Based Materials for Neural Regeneration
  • 8.4.5 Graphene-Based Materials for the Treatment of Stroke
  • 8.4.6 Graphene-Based Materials for the Treatment of Parkinson's Disease
  • 8.4.7 Graphene-Based Materials for the Treatment of Epilepsy
  • 8.4.8 Graphene-Based Materials for Treatment of Multiple Sclerosis
  • 8.5 Conclusion
  • Acknowledgments
  • References
  • 9 Antimicrobial Activities of Graphene-Based Materials
  • 9.1 Introduction
  • 9.2 Antimicrobial Activities of BGMs
  • 9.2.1 Antibacterial Activities
  • 9.2.2 Antifungal Activities
  • 9.2.3 Antiviral Activities
  • 9.3 Toxicological Effect of GBMs
  • 9.4 Conclusion
  • Acknowledgments
  • References
  • 10 Graphene Quantum Dots-A New Member of the Graphene Family: Structure, Properties, and Biomedical Applications
  • 10.1 Structure of Graphene Quantum Dots
  • 10.2 Synthesis of GQDs
  • 10.2.1 Bottom-Up Synthetic Approaches
  • 10.2.2 Top-Down Synthetic Approaches
  • 10.3 Morphological and Optical Properties
  • 10.4 Applications
  • 10.5 Biological Properties of GQDs
  • 10.5.1 Cytotoxicity
  • 10.5.2 GQD in Biosensing
  • 10.5.2.1 Photoluminescencent GQD Biosensors
  • 10.5.2.2 Electrochemical GQD Biosensors
  • 10.5.2.3 Electrochemiluminescence Biosensor Based on GQD
  • 10.5.3 GQD as an Agent in Bioimaging.